← FDA Drug Approvals (Drugs@FDA)
NEOSTIGMINE METHYLSULFATE
NDA · New Drug Application · Sponsor: FRESENIUS KABI USA · Approved 2015-01-08
Drug application
- FDA Application #
NDA203629
- Application type
- New Drug Application
- Brand name
- NEOSTIGMINE METHYLSULFATE
- Generic name
- NEOSTIGMINE METHYLSULFATE
- Active ingredients
- NEOSTIGMINE METHYLSULFATE
- Dosage form
- SOLUTION
- Route
- INTRAVENOUS
- Marketing status
- Prescription
- Sponsor
- FRESENIUS KABI USA
- Manufacturer
- Fresenius Kabi USA, LLC
- First approval
- 2015-01-08
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown